The financial metrics for GlaxoSmithKline plc presented below are for the financial year 2021.
PEG
-0.91
Trailing Price/Earnings To Growth Ratio
EV/Sales
3.82
Enterprise Value To Sales Ratio
EBIT/EV
0.04
EBIT To Enterprise Value Ratio
EV/EBITDA
16.2
Enterprise Value to EBITDA Ratio
D/E
3.84
Debt To Equity Ratio
ROE
29.59%
Return On Equity
ROIC
14.77%
Return On Invested Capital
DPR
91.2%
Dividend Payout Ratio
Current Ratio
0.79
Current Liquidity Ratio
EPS Growth
-27.57%
Earnings Per Share Growth Rate
Graham Number
$18.34
Benjamin Graham's Number
Piotroski Score
N/A
Piotroski F-Score
Beta
N/A
Beta Coefficient Value